AMD - Age-Related Macular Degeneration Clinical Trials
3 recruiting trials for AMD - Age-Related Macular Degeneration. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT07427160
Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages
This study investigates the prognostic value of macular neovascularization (MNV) subtypes in patients treated with pneumatic displacement for submacular hemorrhage. The...
Sponsor: Marco MazzolaEnrolling: 601 location
RECRUITINGPhase 1NCT07330674
A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
This is a Phase 1 study to evaluate the safety, tolerability, PK, and PD of ABF-101 in healthy participants and participants with age-related macular degeneration (AMD).
Sponsor: Aptabio Therapeutics, Inc.Enrolling: 681 location
RECRUITINGNCT07135570
"My Eyes, My Light": Amar Chokh, Amar Alo
Eye disease affects 2.2 billion people globally, which in turn adversely affects schooling, economic productivity, and participation in social life. The primary conditions...
Sponsor: Data Yakka, Inc.Enrolling: 200001 location